77 related articles for article (PubMed ID: 19372996)
1. Wanted: correlates of vaccine-induced protection against simian immunodeficiency virus.
Friedrich TC; Watkins DI
Curr Opin HIV AIDS; 2008 May; 3(3):393-8. PubMed ID: 19372996
[TBL] [Abstract][Full Text] [Related]
2. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
[TBL] [Abstract][Full Text] [Related]
3. Probing the possibilities for T-cell-based AIDS vaccines.
Garber DA; Feinberg MB
Curr Opin HIV AIDS; 2006 Jul; 1(4):314-22. PubMed ID: 19372827
[TBL] [Abstract][Full Text] [Related]
4. Correlates of antibody-mediated protection against HIV infection.
Sattentau Q
Curr Opin HIV AIDS; 2008 May; 3(3):368-74. PubMed ID: 19372992
[TBL] [Abstract][Full Text] [Related]
5. [HIV/AIDS vaccines: heading for new vaccine approaches?].
Girard MP
Bull Soc Pathol Exot; 2008 Jun; 101(3):220-6. PubMed ID: 18681215
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of primate models for AIDS.
Haigwood NL
AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
[TBL] [Abstract][Full Text] [Related]
7. Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.
Das AT; Klaver B; Harwig A; Vink M; Ooms M; Centlivre M; Berkhout B
J Virol; 2007 Oct; 81(20):11159-69. PubMed ID: 17670816
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic mechanisms in simian immunodeficiency virus infection.
Grossman Z; Picker LJ
Curr Opin HIV AIDS; 2008 May; 3(3):380-6. PubMed ID: 19372994
[TBL] [Abstract][Full Text] [Related]
9. AIDS pathogenesis: a tale of two monkeys.
Silvestri G
J Med Primatol; 2008 Dec; 37 Suppl 2():6-12. PubMed ID: 19187426
[TBL] [Abstract][Full Text] [Related]
10. Developing a neonatal HIV vaccine: insights from macaque models of pediatric HIV/AIDS.
Marthas ML; Miller CJ
Curr Opin HIV AIDS; 2007 Sep; 2(5):367-74. PubMed ID: 19372914
[TBL] [Abstract][Full Text] [Related]
11. Lessons learned from the natural hosts of HIV-related viruses.
Paiardini M; Pandrea I; Apetrei C; Silvestri G
Annu Rev Med; 2009; 60():485-95. PubMed ID: 19630581
[TBL] [Abstract][Full Text] [Related]
12. Species barrier of HIV-1 and its jumping by virus engineering.
Nomaguchi M; Doi N; Kamada K; Adachi A
Rev Med Virol; 2008; 18(4):261-75. PubMed ID: 18386279
[TBL] [Abstract][Full Text] [Related]
13. Protection afforded by live attenuated SIV is associated with rapid killing kinetics of CTLs.
Rollman E; Mason RD; Lin J; Brooks AG; Kent SJ
J Med Primatol; 2008 Dec; 37 Suppl 2():24-32. PubMed ID: 19187428
[TBL] [Abstract][Full Text] [Related]
14. Phenotype and function of protective T cell immune responses in HIV.
Betts MR; Harari A
Curr Opin HIV AIDS; 2008 May; 3(3):349-55. PubMed ID: 19372989
[TBL] [Abstract][Full Text] [Related]
15. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
16. Melanoma vaccines.
Riley LB; Agarwala SS
Expert Rev Vaccines; 2008 Sep; 7(7):937-49. PubMed ID: 18767944
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.
Rodríguez A; Mintardjo R; Tax D; Gillissen G; Custers J; Pau MG; Klap J; Santra S; Balachandran H; Letvin NL; Goudsmit J; Radosević K
Vaccine; 2009 Oct; 27(44):6226-33. PubMed ID: 19686691
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus 5- and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection.
Soloff AC; Liu X; Gao W; Day RD; Gambotto A; Barratt-Boyes SM
Eur J Immunol; 2009 Sep; 39(9):2437-49. PubMed ID: 19670380
[TBL] [Abstract][Full Text] [Related]
19. The promise and challenge of anti-HIV cellular immunity.
Borrow P; Turnbull EL
Curr Opin HIV AIDS; 2006 Jul; 1(4):277-85. PubMed ID: 19372822
[TBL] [Abstract][Full Text] [Related]
20. Correlates of immune protection and the development of a human immunodeficiency virus vaccine.
Letvin NL
Immunity; 2007 Sep; 27(3):366-9. PubMed ID: 17892845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
